A New Dawn for Millions of Survivors
In Germany, a coalition of politicians who have personally battled cancer is leading a historic push for a law known as the right to be forgotten (RTBF). This policy would prevent people who have been declared cancer-free from being penalized when they apply for bank loans, adopt children, or take out insurance policies. The goal is to allow survivors to rebuild their lives without the shadow of their medical history.
What Is the Right to Be Forgotten?
In health contexts, RTBF means that once a patient has overcome cancer and a medically justified waiting period (typically five years) has passed, they cannot be forced to disclose their previous diagnosis. This gives them a fresh start, free from discrimination based on past illness.
Key Numbers at a Glance
- 5.5 million: Cancer survivors in Germany.
- 77%: Survivors who face discrimination when applying for private insurance.
- Over 80%: Cure rate for young adults (18–39) and children diagnosed each year in Germany (16,500 and 2,100 respectively).
Voices from the Frontline
The initiative is spearheaded by members of the Social Democratic Party (SPD), Germany’s center-left party. Adis Ahmetović, 33, the SPD’s foreign policy spokesperson, was diagnosed with lymphoma at age 30. He has been tumor-free since October 2024 and could be considered medically cancer-free by 2029. Ahmetović stressed that the measure would cost the state nothing.
Another key advocate is Lars Klingbeil, co-chair of the SPD and Germany’s Finance Minister, who overcame tongue cancer diagnosed in 2014. “Anyone who has beaten cancer must be able to look forward freely, socially and economically,” Klingbeil said.
The campaign also draws strength from ordinary citizens. Tobias Burggraf started a petition after his daughter was diagnosed with cancer at age two and a half. The petition has already gathered over 55,000 signatures. Burggraf captured the spirit of the proposal: “After healing, life begins – not the next obstacle.”
The European Landscape
Manuela Schwesig, premier of the state of Mecklenburg-Western Pomerania and a breast cancer survivor, noted that Germany lags behind other European Union countries. “Other EU states have already solved this. We need a law,” she emphasized.
Currently, only 11 EU member states have introduced specific legal measures, leaving 16 without equivalent protections. The European Society for Medical Oncology advocates for a common standard based on a minimum of five years of remission. Although an EU directive allows restrictions of up to 15 years, advocates consider that period excessive. For context, Ireland passed a similar law in 2026, and the United Kingdom has a voluntary framework.
The Insurance Industry’s View
The German Insurance Association (GDV) has warned against fixed time limits. Jörg Asmussen, GDV’s managing director, argued that insurers need to assess future risks to keep policies affordable, citing possible relapses or long-term effects.
However, Susanne Weg-Remers of the German Cancer Research Center in Heidelberg clarified that the risk of developing tumors in other organs is not significantly higher than in the general population. “Given that one in two men and one in two to three women in Germany will develop a malignant tumor at some point in their lives,” Weg-Remers said, “if cancer were used as an argument, no insurance or loan would ever be granted.”
Source: The Guardian